A Case of Chronic Myelomonocytic Leukemia Who Developed Pericardial Effusion during Stably Controlled Leukocytosis
-
- Morita Yasuyoshi
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Ohyama Yuichi
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Rai Shinya
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Kawauchi Masaya
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Yamaguchi Terufumi
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Shimada Takahiro
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Tatsumi Yoichi
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Ashida Takashi
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Maeda Yasuhiro
- Department of Hematology, Kinki University School of Medicine, Japan
-
- Matsumura Itaru
- Department of Hematology, Kinki University School of Medicine, Japan
この論文をさがす
抄録
We report a rare case of chronic myelomonocytic leukemia (CMML) with pericardial effusion. After receving the diagnosis of CMML, she had been successfully treated with hydroxycarbamide (HU). However, she was admitted to our hospital due to pericardial effusion. The majority of the cells in the pericardial fluid were monocytes. We made the diagnosis of pericardial involvement with CMML cells and intravenously administered etoposide (100 mg/body daily for 5 days). Although CMML cells disappeared from the peripheral blood, the pericardial effusion still persisted. This case indicates that pericardial effusion is a possible and life-threatening complication in CMML patients despite stably controlled leukocytes.<br>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 50 (16), 1737-1740, 2011
一般社団法人 日本内科学会
